furazabol

呋咱甲氢龙

Report date: 2022/08/17 14:34:51

Base Information

Drug Namefurazabol
Drug Alias NameFrazalon去脂舒androfurazanol雄异噁唑Miotolon +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAndrogen Receptor agonists
TargetsAndrogen Receptor
Therapy Area/IndicationsHyperlipidemiasAtherosclerosis
Global Approved IndicationsHyperlipidemiasAtherosclerosis
Approved Indications in ChinaHyperlipidemiasAtherosclerosis
Original Approved Country/TerritoryMainland China
Original Approved Date1993/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesBestway Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsHyperlipidemiasAtherosclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A